Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate

N/A

Report date: 2022/12/24 20:00:29
NME

Base Information

Drug NameTyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate
Drug Alias NameAmbervin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPromomed LLC
China Registration ClassN/A

Develop Information

Active CompaniesPromomed LLC
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A